Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden · Delayed Price · Currency is SEK 97.40
-2.30 (-2.31%)
May 26, 2026, 5:24 PM CET
Devyser Diagnostics AB Market Cap
Devyser Diagnostics AB has a market cap or net worth of 1.64 billion as of May 26, 2026. Its market cap has decreased by -6.81% in one year.
Market Cap
1.64B
Enterprise Value
1.61B
Revenue
257.50M
Ranking
n/a
PE Ratio
108.86
Stock Price
97.40
Market Cap Chart
Since December 10, 2021, Devyser Diagnostics AB's market cap has increased from 1.35B to 1.64B, an increase of 20.97%. That is a compound annual growth rate of 4.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 25, 2026 | 1.67B | -11.99% |
| Dec 30, 2025 | 1.90B | -2.79% |
| Dec 30, 2024 | 1.96B | 52.85% |
| Dec 29, 2023 | 1.28B | 11.06% |
| Dec 30, 2022 | 1.15B | -14.36% |
| Dec 30, 2021 | 1.35B | -0.45% |
| Dec 10, 2021 | 1.35B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CellaVision AB | 2.97B |
| BICO Group AB | 1.36B |
| Paxman AB | 1.20B |
| C-Rad AB | 1.18B |
| Sedana Medical AB | 978.47M |
| Episurf Medical AB | 818.42M |
| Senzime AB | 728.69M |
| Bactiguard Holding AB | 557.20M |